Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Løkke A[au]:

Search results

Items: 1 to 50 of 63

1.

Direct and indirect economic and health consequences related to sarcoidosis in Denmark: A national register-based study.

Gade Sikjær M, Hilberg O, Ibsen R, Bock K, Løkke A.

Respir Med. 2019 Jun;152:7-13. doi: 10.1016/j.rmed.2019.04.004. Epub 2019 Apr 9.

PMID:
31128613
2.

Advance care planning and place of death, hospitalisation and actual place of death in lung, heart and cancer disease: a randomised controlled trial.

Skorstengaard MH, Jensen AB, Andreassen P, Brogaard T, Brendstrup E, Løkke A, Aagaard S, Wiggers H, Neergaard MA.

BMJ Support Palliat Care. 2019 Apr 11. pii: bmjspcare-2018-001677. doi: 10.1136/bmjspcare-2018-001677. [Epub ahead of print]

PMID:
30975712
3.

The stillbirth sex ratio as a marker of population health among live-born males in Denmark, 1835-1923.

Bruckner TA, Singh P, Mortensen LH, Løkke A.

Am J Hum Biol. 2019 May;31(3):e23241. doi: 10.1002/ajhb.23241. Epub 2019 Mar 25.

PMID:
30908834
4.

Advance care planning for patients and their relatives.

Skorstengaard MH, Brogaard T, Jensen AB, Andreassen P, Bendstrup E, Løkke A, Aagaard S, Wiggers H, Johnsen AT, Neergaard MA.

Int J Palliat Nurs. 2019 Mar 2;25(3):112-127. doi: 10.12968/ijpn.2019.25.3.112.

PMID:
30892997
5.

Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study.

Jensen ML, Løkke A, Hilberg O, Hyldgaard C, Bendstrup E, Tran D.

Eur Clin Respir J. 2019 Feb 27;6(1):1583516. doi: 10.1080/20018525.2019.1583516. eCollection 2019.

6.

[Environmental tobacco smoke is a risk factor for the development of chronic obstructive pulmonary disease].

Robertson S, Pisinger CH, Løkke A, Godtfredsen NS.

Ugeskr Laeger. 2019 Feb 18;181(8). pii: V08180584. Danish.

PMID:
30821243
7.

In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) in Aspergillus fumigatus cyp51A, Denmark.

Hare RK, Gertsen JB, Astvad KMT, Degn KB, Løkke A, Stegger M, Andersen PS, Kristensen L, Arendrup MC.

Emerg Infect Dis. 2019 Mar;25(3):577-580. doi: 10.3201/eid2503.180297.

8.

A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study.

Lehmann S, Ringbæk T, Løkke A, Grote L, Hedner J, Lindberg E.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 9;14:199-210. doi: 10.2147/COPD.S184127. eCollection 2019.

9.

[Individualised treatment of patients with bronchoectasis].

Hilberg O, Hyldgaard C, Løkke A, Andersen C, Lange P.

Ugeskr Laeger. 2018 Dec 3;180(49). pii: V02180104. Danish.

PMID:
30520717
10.

Barriers and motivational factors towards physical activity in daily life living with COPD - an interview based pilot study.

Østergaard EB, Sritharan SS, Kristiansen AD, Thomsen PM, Løkke A.

Eur Clin Respir J. 2018 Jul 6;5(1):1484654. doi: 10.1080/20018525.2018.1484654. eCollection 2018.

11.

[Smoking cessation and lung cancer treatment].

Løkke A, Christensen NL, Rasmussen TR.

Ugeskr Laeger. 2018 Oct 29;180(44). pii: V01180058. Danish.

PMID:
30375965
12.

Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases.

Marsaa K, Gundestrup S, Jensen JU, Lange P, Løkke A, Roberts NB, Shaker SB, Sørensen AR, Titlestad IL, Thomsen LH, Weinreich UM, Bendstrup E, Wilcke T.

Eur Clin Respir J. 2018 Oct 16;5(1):1530029. doi: 10.1080/20018525.2018.1530029. eCollection 2018. Review.

13.

The impact of pulmonary rehabilitation on severe physical inactivity in patients with chronic obstructive pulmonary disease: a pilot study.

Thyregod M, Løkke A, Bodtger U.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 12;13:3359-3365. doi: 10.2147/COPD.S174710. eCollection 2018.

14.

[Examination for osteoporosis in patients with chronic obstructive pulmonary disease].

Johansen NJ, Harsløf T, Hermann AP, Andersen CU, Hilberg O, Løkke A.

Ugeskr Laeger. 2018 Oct 1;180(40). pii: V12170934. Danish.

PMID:
30274583
15.

[Treatment limitations or discontinuation in patients with benign pulmonary diseases].

Sørensen AR, Bendstrup E, Løkke A, Titlestad IL, Jensen JU, Thomsen L, Roberts N, Gjørup P, Shaker S, Gundestrup S, Wilcke T, Weinreich UM, Marsaa K.

Ugeskr Laeger. 2018 Sep 24;180(39). pii: V04180270. Danish.

PMID:
30274574
16.

Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients.

Christensen NL, Løkke A, Dalton SO, Christensen J, Rasmussen TR.

Lung Cancer. 2018 Oct;124:40-44. doi: 10.1016/j.lungcan.2018.07.025. Epub 2018 Jul 20.

PMID:
30268478
17.

[Sarcoidosis].

Møller J, Hellmund V, Hilberg O, Løkke A.

Ugeskr Laeger. 2018 Aug 20;180(34). pii: V10170777. Danish.

PMID:
30152318
18.

Asymptomatic dysphagia causing recurrent aspiration pneumonia.

Løkke A, Dongo LC, Aksglæde KB, Hilberg O.

BMJ Case Rep. 2018 Aug 20;2018. pii: bcr-2018-224370. doi: 10.1136/bcr-2018-224370.

19.

Lack of awareness towards smoking-related health risks, symptoms related to COPD, and attitudinal factors concerning smoking: an Internet-based survey conducted in a random sample of the Danish general population.

Sikjær MG, Hilberg O, Fløe A, Dollerup J, Løkke A.

Eur Clin Respir J. 2018 Aug 14;5(1):1506235. doi: 10.1080/20018525.2018.1506235. eCollection 2018.

20.

Persistent cough - A rare presentation of hepatocellular carcinoma.

Sandahl OG, Hilberg O, Rasmussen F, Løkke A.

Respir Med Case Rep. 2018 May 4;24:103-104. doi: 10.1016/j.rmcr.2018.04.013. eCollection 2018.

21.

Increased mortality among patients with rheumatoid arthritis and COPD: A population-based study.

Hyldgaard C, Bendstrup E, Pedersen AB, Ulrichsen SP, Løkke A, Hilberg O, Ellingsen T.

Respir Med. 2018 Jul;140:101-107. doi: 10.1016/j.rmed.2018.06.010. Epub 2018 Jun 8.

PMID:
29957269
22.

The Area method: a new method for ultrasound assessment of diaphragmatic movement.

Skaarup SH, Løkke A, Laursen CB.

Crit Ultrasound J. 2018 Jun 27;10(1):15. doi: 10.1186/s13089-018-0092-5.

23.

Tele-delivered mindfulness-based cognitive therapy in chronic obstructive pulmonary disease: A mixed-methods feasibility study.

Farver-Vestergaard I, O'Connor M, Smith NC, Løkke A, Bendstrup E, Zachariae R.

J Telemed Telecare. 2019 Sep;25(8):468-475. doi: 10.1177/1357633X18780563. Epub 2018 Jun 25.

PMID:
29940797
24.

[Treatment of stable chronic obstructive pulmonary disease].

Løkke A, Nielsen LP, Moberg M, Marså K, Titlestad IL, Kofod LM, Godtfredsen NS.

Ugeskr Laeger. 2018 Jun 18;180(25). pii: V11170855. Danish.

PMID:
29938633
25.

Economic consequences of idiopathic pulmonary fibrosis in Denmark.

Hilberg O, Bendstrup E, Ibsen R, Løkke A, Hyldgaard C.

ERJ Open Res. 2018 May 25;4(2). pii: 00045-2017. doi: 10.1183/23120541.00045-2017. eCollection 2018 Apr.

26.

Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.

Tupper OD, Kjeldgaard P, Løkke A, Ulrik CS.

Chron Respir Dis. 2018 Nov;15(4):393-399. doi: 10.1177/1479972318761655. Epub 2018 Feb 27.

27.

The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.

Sikjær MG, Løkke A, Hilberg O.

Respir Med. 2018 Feb;135:35-41. doi: 10.1016/j.rmed.2017.12.012. Epub 2018 Jan 3.

PMID:
29414451
28.

Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial.

Farver-Vestergaard I, O'Toole MS, O'Connor M, Løkke A, Bendstrup E, Basdeo SA, Cox DJ, Dunne PJ, Ruggeri K, Early F, Zachariae R.

Eur Respir J. 2018 Jan 31;51(2). pii: 1702082. doi: 10.1183/13993003.02082-2017. Print 2018 Feb.

29.

Mrs Stone and Dr Smellie: British eighteenth-century birth attendance and long-run levels and trends in maternal mortality discussed in a north European context.

Løkke A.

Popul Stud (Camb). 2018 Mar;72(1):123-136. doi: 10.1080/00324728.2017.1415036. Epub 2018 Jan 23.

PMID:
29357758
30.

Co-morbidity and mortality among patients with interstitial lung diseases: A population-based study.

Hilberg O, Bendstrup E, Løkke A, Ibsen R, Fløe A, Hyldgaard C.

Respirology. 2018 Jun;23(6):606-612. doi: 10.1111/resp.13234. Epub 2017 Dec 18.

PMID:
29251396
31.

Comorbidities, mortality and causes of death among patients with tuberculosis in Denmark 1998-2010: a nationwide, register-based case-control study.

Fløe A, Hilberg O, Wejse C, Ibsen R, Løkke A.

Thorax. 2018 Jan;73(1):70-77. doi: 10.1136/thoraxjnl-2016-209240. Epub 2017 Aug 4.

PMID:
28778918
32.

Dietary beetroot juice - effects on physical performance in COPD patients: a randomized controlled crossover trial.

Friis AL, Steenholt CB, Løkke A, Hansen M.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 15;12:1765-1773. doi: 10.2147/COPD.S135752. eCollection 2017.

33.

Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review.

Bock K, Bendstrup E, Hilberg O, Løkke A.

Eur Clin Respir J. 2017 Jan 1;4(1):1332931. doi: 10.1080/20018525.2017.1332931. eCollection 2017.

34.

A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.

Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Løkke A, Bendstrup E, Ellingsen T.

Ann Rheum Dis. 2017 Oct;76(10):1700-1706. doi: 10.1136/annrheumdis-2017-211138. Epub 2017 Jun 13.

PMID:
28611082
35.

Preferred Place of Care and Death in Terminally Ill Patients with Lung and Heart Disease Compared to Cancer Patients.

Skorstengaard MH, Neergaard MA, Andreassen P, Brogaard T, Bendstrup E, Løkke A, Aagaard S, Wiggers H, Bech P, Jensen AB.

J Palliat Med. 2017 Nov;20(11):1217-1224. doi: 10.1089/jpm.2017.0082. Epub 2017 Jun 2.

PMID:
28574737
36.
37.

Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.

Durfee PN, Lin YS, Dunphy DR, Muñiz AJ, Butler KS, Humphrey KR, Lokke AJ, Agola JO, Chou SS, Chen IM, Wharton W, Townson JL, Willman CL, Brinker CJ.

ACS Nano. 2016 Sep 27;10(9):8325-45. doi: 10.1021/acsnano.6b02819. Epub 2016 Jul 25.

PMID:
27419663
38.

Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia.

Søgaard M, Madsen M, Løkke A, Hilberg O, Sørensen HT, Thomsen RW.

Int J Chron Obstruct Pulmon Dis. 2016 Mar 2;11:455-65. doi: 10.2147/COPD.S96179. eCollection 2016.

39.

Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.

Løkke A, Ahlbeck L, Bjermer L, Mortensen J, Østrem A, Pasternack I, Safioti G, Torvinen S.

Eur Clin Respir J. 2015 Dec 16;2:29445. doi: 10.3402/ecrj.v2.29445. eCollection 2015.

40.

Airway foreign body aspiration: common, yet easily overlooked! Two interesting cases.

Møller J, Rasmussen F, Hilberg O, Løkke A.

BMJ Case Rep. 2015 May 22;2015. pii: bcr2014209240. doi: 10.1136/bcr-2014-209240.

41.

The economic burden of tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses.

Fløe A, Hilberg O, Wejse C, Løkke A, Ibsen R, Kjellberg J, Jennum P.

Int J Infect Dis. 2015 Mar;32:183-90. doi: 10.1016/j.ijid.2014.12.021.

42.

Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?

Kjeldgaard P, Dahl R, Løkke A, Ulrik CS.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.

43.

[COPD and perception of the new GOLD document in Europe. Workshop from the Société de pneumologie de langue française (SPLF)].

Zysman M, Patout M, Miravitlles M, van der Molen T, Lokke A, Hausen T, Didier A, Cuvelier A, Roche N.

Rev Mal Respir. 2014 Jun;31(6):499-510. doi: 10.1016/j.rmr.2014.02.014. Epub 2014 May 9. Review. French.

PMID:
25012036
44.

Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998-2010.

Løkke A, Hilberg O, Tønnesen P, Ibsen R, Kjellberg J, Jennum P.

BMJ Open. 2014 Jan 6;4(1):e004069. doi: 10.1136/bmjopen-2013-004069.

45.

Economic and health consequences of COPD patients and their spouses in Denmark--1998-2010.

Løkke A, Hilberg O, Kjellberg J, Ibsen R, Jennum P.

COPD. 2014 Jun;11(3):237-46. doi: 10.3109/15412555.2013.839647. Epub 2013 Dec 19.

PMID:
24354969
46.

Severe interstitial lung disease following treatment with certolizumab pegol: a case report.

Lager J, Hilberg O, Løkke A, Bendstrup E.

Eur Respir Rev. 2013 Sep 1;22(129):414-6. doi: 10.1183/09059180.00002013. No abstract available.

47.

[New guidelines for diagnosis and staging of chronic obstructive pulmonary disease].

Løkke A, Dahl R.

Ugeskr Laeger. 2013 Apr 29;175(18):1257-60. Review. Danish.

PMID:
23651801
48.

Impact of diagnostic criteria on the prevalence of COPD.

Çolak Y, Løkke A, Marott JL, Lange P, Vestbo J.

Clin Respir J. 2013 Jul;7(3):297-303. doi: 10.1111/crj.12007. Epub 2012 Nov 22.

PMID:
23072716
49.

Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice.

Løkke A, Ulrik CS, Dahl R, Plauborg L, Dollerup J, Kristiansen LC, Cording PH, Dehlendorff C; TOP GOLD study-group.

COPD. 2012 Aug;9(5):458-65. doi: 10.3109/15412555.2012.685118. Epub 2012 May 29.

PMID:
22643016
50.

New Danish reference values for spirometry.

Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M, Lange P.

Clin Respir J. 2013 Apr;7(2):153-67.

PMID:
22583805

Supplemental Content

Support Center